Advancing medicines
Aquestive Therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical therapeutic problems and meaningfully improve people’s lives. We apply innovative drug delivery technology and scientific expertise to redesign important medicines. Our initial focus, supported by our current approved products and late stage pipeline, is to improve medications and outcomes for patients with central nervous system (CNS) conditions.
Our success is proven
2
Billion PharmFilm doses consumed by patients
200+
Worldwide patents
4
Continents where our products are sold
Latest news
-
Aquestive Therapeutics Announces Late-Breaking Findings of its Investigational Diazepam Buccal Film (DBF) Formulation in Adults with Epilepsy
December, 03 2018 at 11:00 AM EST -- Studies show DBF, tentatively named Libervant™, was successfully administered and had similar bioavailability whether given during/immediately following ...
-
Aquestive Therapeutics Launches SYMPAZAN™ (clobazam) Oral Film with Widespread U.S. Availability
November, 29 2018 at 12:16 PM EST Establishes extensive Authorized Distributor Network to ensure easy access through retail pharmacies nationwide and mail order WARREN, N.J., Nov. 29, 2018 /PRNewswire...
